Friday, October 3, 2025

Global Farm Animal External Dewormer Market Research Report 2025

What is Global Farm Animal External Dewormer Market?

The Global Farm Animal External Dewormer Market is a crucial segment within the broader animal healthcare industry, focusing on products designed to eliminate parasitic worms that infest farm animals externally. These dewormers are essential for maintaining the health and productivity of livestock, which includes cattle, equine, swine, and poultry. The market encompasses a variety of products, such as injections, unguents, and other formulations, tailored to different types of animals and their specific needs. The demand for these products is driven by the need to enhance animal health, improve meat and dairy production, and ensure food safety. As the global population continues to grow, the demand for animal protein increases, further propelling the need for effective deworming solutions. Additionally, the market is influenced by factors such as advancements in veterinary medicine, increased awareness among farmers about animal health, and stringent regulations regarding food safety. The market is characterized by a mix of established players and new entrants, all striving to innovate and offer more effective and safer deworming solutions. Overall, the Global Farm Animal External Dewormer Market plays a vital role in supporting the agricultural sector and ensuring the well-being of farm animals worldwide.

Farm Animal External Dewormer Market

Injection, Unguent in the Global Farm Animal External Dewormer Market:

In the realm of the Global Farm Animal External Dewormer Market, injections and unguents are two prominent forms of deworming solutions that cater to the diverse needs of livestock. Injections are a popular choice due to their efficacy and ease of administration. They are typically administered by veterinarians or trained personnel, ensuring precise dosage and rapid action against parasites. Injections work by delivering active ingredients directly into the animal's bloodstream, providing a swift and potent response to parasitic infestations. This method is particularly beneficial for large-scale farms where managing a vast number of animals efficiently is crucial. The active ingredients in these injections are designed to target specific parasites, ensuring that the treatment is both effective and safe for the animals. On the other hand, unguents, or topical applications, offer a different approach to deworming. These are applied directly to the skin of the animal, where they are absorbed and act against external parasites. Unguents are often preferred for their ease of use, especially in smaller farms or for animals that are difficult to handle. They provide a non-invasive method of treatment, reducing stress on the animals and minimizing the risk of injury during administration. The choice between injections and unguents often depends on various factors, including the type of animal, the severity of the infestation, and the farm's operational capabilities. For instance, in cattle, injections might be favored due to the animals' size and the need for precise dosing, while unguents could be more suitable for smaller animals or those with sensitive skin. Both forms of dewormers are subject to rigorous testing and regulation to ensure their safety and effectiveness. Manufacturers invest heavily in research and development to create formulations that are not only potent against parasites but also safe for the animals and the environment. This includes developing products that minimize the risk of resistance, a growing concern in the field of veterinary medicine. The market for these products is highly competitive, with companies striving to differentiate themselves through innovation and quality. Injections and unguents are often part of a broader deworming strategy that includes regular monitoring of animal health, proper nutrition, and hygiene practices. Farmers and livestock owners are increasingly aware of the importance of integrated pest management, which combines chemical treatments with other preventive measures to maintain animal health and productivity. This holistic approach is essential for sustainable farming practices and aligns with the growing consumer demand for ethically produced animal products. In conclusion, injections and unguents represent two vital components of the Global Farm Animal External Dewormer Market, each offering unique benefits and challenges. Their role in maintaining animal health and supporting the agricultural industry cannot be overstated, as they contribute significantly to the overall well-being of livestock and the quality of animal-derived products.

Cattle, Equine, Swine, Poultry in the Global Farm Animal External Dewormer Market:

The usage of Global Farm Animal External Dewormer Market products varies significantly across different types of livestock, including cattle, equine, swine, and poultry, each with its unique requirements and challenges. In cattle, dewormers are crucial for preventing and controlling parasitic infestations that can lead to weight loss, reduced milk production, and overall poor health. Cattle are often exposed to a variety of parasites due to their grazing habits, making regular deworming an essential part of herd management. Injections are commonly used in cattle due to their effectiveness and the ease of administering them to large animals. These treatments help ensure that cattle remain healthy and productive, ultimately supporting the dairy and beef industries. For equine, or horses, deworming is equally important, as parasites can cause significant health issues, including colic, weight loss, and poor coat condition. Horses are often treated with a combination of oral and topical dewormers, tailored to their specific needs and the types of parasites they are exposed to. Regular deworming schedules are critical for maintaining the health and performance of horses, whether they are used for work, sport, or leisure. In the swine industry, dewormers play a vital role in ensuring the health and growth of pigs. Swine are susceptible to both internal and external parasites, which can impact their growth rates and overall health. Deworming treatments, often administered through feed or water, help control these parasites and improve the efficiency of pork production. The use of dewormers in swine is closely monitored to ensure that residues do not enter the food chain, aligning with food safety regulations. Poultry, including chickens, turkeys, and other birds, also benefit from deworming treatments, although the approach differs from that used in larger livestock. Poultry are often treated with dewormers mixed into their feed or water, targeting specific parasites that can affect their health and egg production. Maintaining parasite-free poultry is essential for ensuring high-quality meat and eggs, which are staples in many diets worldwide. The use of dewormers in poultry is part of a broader biosecurity strategy that includes proper housing, nutrition, and hygiene practices. Across all these livestock categories, the Global Farm Animal External Dewormer Market provides essential tools for maintaining animal health and productivity. The choice of deworming products and methods depends on various factors, including the type of animal, the specific parasites present, and the farm's operational practices. Farmers and livestock owners must stay informed about the latest developments in deworming technology and best practices to ensure the well-being of their animals and the success of their operations. Overall, the effective use of dewormers is a critical component of modern livestock management, supporting the agricultural industry and contributing to global food security.

Global Farm Animal External Dewormer Market Outlook:

In 2024, the Global Farm Animal External Dewormer Market was valued at approximately $2,827 million. This market is anticipated to expand significantly, reaching an estimated value of $3,959 million by 2031. This growth trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period. This upward trend underscores the increasing demand for effective deworming solutions in the agricultural sector. The growth is driven by several factors, including the rising awareness among farmers about the importance of maintaining animal health and the need to enhance productivity in livestock farming. As the global population continues to grow, the demand for animal protein is also on the rise, necessitating efficient and safe deworming practices to ensure the health and productivity of farm animals. The market's expansion is further supported by advancements in veterinary medicine and the development of innovative deworming products that offer improved efficacy and safety. Additionally, stringent regulations regarding food safety and animal welfare are prompting farmers to adopt more effective deworming solutions. The competitive landscape of the market is characterized by the presence of both established players and new entrants, all striving to capture a share of this growing market by offering high-quality and innovative products. Overall, the Global Farm Animal External Dewormer Market is poised for significant growth, driven by the increasing demand for effective deworming solutions and the ongoing advancements in veterinary medicine.


Report Metric Details
Report Name Farm Animal External Dewormer Market
Accounted market size in year US$ 2827 million
Forecasted market size in 2031 US$ 3959 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Unguent
Segment by Application
  • Cattle
  • Equine
  • Swine
  • Poultry
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Pets Internal Dewormer Market Research Report 2025

What is Global Pets Internal Dewormer Market?

The Global Pets Internal Dewormer Market is a specialized segment within the broader pet healthcare industry, focusing on products designed to eliminate internal parasites in pets. These parasites, such as worms, can cause significant health issues in animals, ranging from mild discomfort to severe illness. The market encompasses a variety of deworming products, including tablets, powders, and liquids, each formulated to target specific types of worms like roundworms, tapeworms, and hookworms. The demand for these products is driven by increasing pet ownership worldwide, coupled with a growing awareness among pet owners about the importance of regular deworming to maintain their pets' health. Additionally, advancements in veterinary medicine have led to the development of more effective and safer deworming products, further fueling market growth. The market is also influenced by regional factors, such as the prevalence of certain parasites in specific areas and varying regulations regarding veterinary pharmaceuticals. Overall, the Global Pets Internal Dewormer Market plays a crucial role in ensuring the health and well-being of pets, reflecting broader trends in pet care and veterinary medicine.

Pets Internal Dewormer Market

Tablet, Powder in the Global Pets Internal Dewormer Market:

In the Global Pets Internal Dewormer Market, tablets and powders are two of the most common forms of deworming products available for pet owners. Tablets are often favored for their convenience and ease of administration. They are typically formulated to be palatable, making it easier for pet owners to give them to their pets without much resistance. Tablets can be designed to target specific types of worms or offer broad-spectrum protection against multiple parasites. They are usually administered orally and can be given directly to the pet or hidden in food. The dosage and frequency of administration depend on the pet's weight, age, and health condition, as well as the specific product being used. On the other hand, powder dewormers offer a different set of advantages. They can be easily mixed with the pet's food, making them an excellent option for pets that are difficult to medicate with tablets. Powders are often used for larger animals or in situations where precise dosing is required. Like tablets, powder dewormers can be formulated to target specific parasites or provide broad-spectrum protection. The choice between tablets and powders often depends on the pet's preferences, the owner's convenience, and the specific health needs of the pet. Both forms are subject to rigorous testing and regulation to ensure their safety and efficacy. The market for these products is highly competitive, with numerous brands offering a wide range of options to cater to different pet species, sizes, and health conditions. As pet ownership continues to rise globally, the demand for effective and convenient deworming solutions is expected to grow, driving innovation and competition in the market. Manufacturers are continually seeking to improve the palatability, efficacy, and safety of their products to meet the evolving needs of pet owners. Additionally, there is a growing trend towards natural and organic deworming products, reflecting broader consumer preferences for natural health solutions. This trend is likely to influence the development and marketing of new deworming products in the future. Overall, tablets and powders represent essential tools in the fight against internal parasites in pets, each offering unique benefits and challenges for pet owners and veterinarians alike.

Dogs, Cats, Other in the Global Pets Internal Dewormer Market:

The usage of Global Pets Internal Dewormer Market products varies across different types of pets, including dogs, cats, and other animals. For dogs, deworming is a critical aspect of routine health care. Dogs are particularly susceptible to a variety of internal parasites, including roundworms, hookworms, and tapeworms. Regular deworming is essential to prevent these parasites from causing health issues such as digestive problems, weight loss, and anemia. Deworming products for dogs are available in various forms, including tablets, powders, and liquids, allowing pet owners to choose the most suitable option for their pets. Cats, like dogs, are also prone to internal parasites, although the types of worms that affect them can differ. Common parasites in cats include roundworms, tapeworms, and hookworms. Deworming is crucial for maintaining a cat's health, as these parasites can lead to serious health problems if left untreated. Deworming products for cats are available in similar forms to those for dogs, with formulations specifically designed to be safe and effective for feline use. In addition to dogs and cats, other pets, such as rabbits, ferrets, and birds, can also be affected by internal parasites. While the prevalence and types of parasites may vary, deworming remains an important aspect of health care for these animals. Deworming products for other pets are often formulated to address the specific needs and sensitivities of these animals, ensuring their safety and efficacy. The choice of deworming product and the frequency of administration depend on various factors, including the type of pet, its age, weight, and overall health, as well as the specific parasites being targeted. Veterinarians play a crucial role in guiding pet owners in selecting the appropriate deworming regimen for their pets. As awareness of the importance of deworming continues to grow, the Global Pets Internal Dewormer Market is expected to expand, offering a wider range of products to meet the diverse needs of pet owners worldwide.

Global Pets Internal Dewormer Market Outlook:

In 2024, the global market for Pets Internal Dewormer was valued at approximately $3,029 million. This market is anticipated to grow significantly, reaching an estimated value of $4,529 million by 2031. This growth represents a compound annual growth rate (CAGR) of 6.0% over the forecast period. The increasing market size reflects a growing awareness among pet owners about the importance of regular deworming to maintain their pets' health. As more people around the world adopt pets, the demand for effective deworming solutions is expected to rise. This growth is also driven by advancements in veterinary medicine, leading to the development of more effective and safer deworming products. Additionally, the market is influenced by regional factors, such as the prevalence of certain parasites in specific areas and varying regulations regarding veterinary pharmaceuticals. The competitive landscape of the market is characterized by numerous brands offering a wide range of deworming products, catering to different pet species, sizes, and health conditions. As the market continues to expand, manufacturers are likely to focus on innovation and product development to meet the evolving needs of pet owners. This includes the development of natural and organic deworming products, reflecting broader consumer preferences for natural health solutions. Overall, the Global Pets Internal Dewormer Market is poised for significant growth, driven by increasing pet ownership, growing awareness of pet health, and advancements in veterinary medicine.


Report Metric Details
Report Name Pets Internal Dewormer Market
Accounted market size in year US$ 3029 million
Forecasted market size in 2031 US$ 4529 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablet
  • Powder
Segment by Application
  • Dogs
  • Cats
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Pets External Dewormer Market Research Report 2025

What is Global Pets External Dewormer Market?

The Global Pets External Dewormer Market is a specialized segment within the broader pet healthcare industry, focusing on products designed to eliminate parasitic worms from the external environment of pets. These dewormers are crucial for maintaining the health and well-being of pets, as they help prevent infestations that can lead to serious health issues. The market encompasses a variety of products, including topical treatments, injections, and oral medications, each tailored to different types of pets and their specific needs. The demand for external dewormers is driven by the increasing pet ownership worldwide, coupled with a growing awareness among pet owners about the importance of regular deworming. Additionally, advancements in veterinary medicine have led to the development of more effective and safer deworming products, further fueling market growth. The market is also influenced by regional factors, such as climate and the prevalence of certain parasites, which can affect the types of dewormers that are most in demand. Overall, the Global Pets External Dewormer Market plays a vital role in the pet care industry, ensuring that pets remain healthy and free from harmful parasites.

Pets External Dewormer Market

Injection, Unguent in the Global Pets External Dewormer Market:

In the Global Pets External Dewormer Market, injections and unguents are two prominent forms of treatment used to combat parasitic infestations in pets. Injections are often preferred for their quick action and long-lasting effects. They are typically administered by veterinarians and are designed to provide a systemic solution to worm infestations. The active ingredients in these injections are absorbed into the pet's bloodstream, effectively targeting and eliminating parasites throughout the body. This method is particularly beneficial for pets that are difficult to medicate orally or those that require immediate intervention due to severe infestations. On the other hand, unguents, or topical treatments, offer a more localized approach. These are applied directly to the pet's skin, usually at the back of the neck or along the spine, where they are absorbed through the skin and into the bloodstream. Unguents are popular among pet owners for their ease of application and the minimal stress they cause to pets. They are especially useful for treating external parasites like fleas and ticks, which can be a common problem in certain regions. The choice between injections and unguents often depends on the specific needs of the pet, the type of parasites being targeted, and the preferences of the pet owner. Both forms of treatment have their advantages and are integral to the comprehensive management of parasitic infestations in pets. Injections provide a robust and immediate response, making them ideal for severe cases, while unguents offer a convenient and stress-free option for regular maintenance and prevention. The development of these products has been driven by ongoing research and innovation in veterinary medicine, leading to more effective and safer options for pet owners. As the Global Pets External Dewormer Market continues to evolve, the availability and variety of injections and unguents are expected to expand, providing pet owners with even more choices for keeping their pets healthy and parasite-free.

Dogs, Cats, Other in the Global Pets External Dewormer Market:

The usage of Global Pets External Dewormer Market products varies significantly across different types of pets, including dogs, cats, and other animals. For dogs, external dewormers are essential in preventing and treating infestations of parasites such as fleas, ticks, and various types of worms. Dogs are often exposed to these parasites during outdoor activities, making regular deworming a crucial part of their healthcare routine. Products like topical treatments and injections are commonly used, with many dog owners opting for monthly applications to ensure continuous protection. Cats, on the other hand, have different needs when it comes to deworming. While they are also susceptible to fleas and ticks, cats are more likely to contract parasites from hunting small animals or through contact with contaminated environments. As such, cat owners often prefer topical treatments that are easy to apply and specifically formulated for feline physiology. These treatments not only target external parasites but also help in preventing internal infestations. For other pets, such as rabbits, ferrets, and birds, the use of external dewormers is less common but still important in certain situations. These animals may require specialized products that cater to their unique biology and living conditions. For instance, birds might need treatments that are safe for their delicate respiratory systems, while rabbits and ferrets may benefit from products that address specific parasites prevalent in their habitats. The Global Pets External Dewormer Market recognizes the diverse needs of different pets and offers a range of products to meet these requirements. Pet owners are encouraged to consult with veterinarians to determine the most appropriate deworming regimen for their pets, taking into account factors such as age, health status, and lifestyle. By doing so, they can ensure that their pets remain healthy and free from the harmful effects of parasitic infestations.

Global Pets External Dewormer Market Outlook:

In 2024, the global market for Pets External Dewormer was valued at approximately 2,305 million USD. This market is anticipated to grow significantly, reaching an estimated size of 3,446 million USD by the year 2031. This growth is expected to occur at a compound annual growth rate (CAGR) of 6.0% over the forecast period. The increase in market size reflects a growing awareness among pet owners about the importance of regular deworming and the availability of more advanced and effective deworming products. As pet ownership continues to rise globally, so does the demand for high-quality pet healthcare products, including external dewormers. This trend is further supported by advancements in veterinary medicine, which have led to the development of safer and more efficient deworming solutions. The market's growth is also influenced by regional factors, such as the prevalence of certain parasites and the climate, which can affect the types of dewormers that are most in demand. Overall, the Global Pets External Dewormer Market is poised for substantial growth, driven by increasing pet ownership, advancements in product development, and a heightened focus on pet health and wellness.


Report Metric Details
Report Name Pets External Dewormer Market
Accounted market size in year US$ 2305 million
Forecasted market size in 2031 US$ 3446 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Unguent
Segment by Application
  • Dogs
  • Cats
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Companion Animal Internal Dewormer Market Research Report 2025

What is Global Companion Animal Internal Dewormer Market?

The Global Companion Animal Internal Dewormer Market is a specialized segment within the broader veterinary pharmaceutical industry, focusing on products designed to eliminate internal parasites in pets such as dogs, cats, and other companion animals. These dewormers are crucial for maintaining the health and well-being of pets, as internal parasites can lead to severe health issues if left untreated. The market encompasses a variety of products, including tablets, powders, and liquids, each tailored to different types of animals and their specific needs. The demand for these products is driven by increasing pet ownership worldwide, heightened awareness about pet health, and the growing trend of treating pets as family members. Additionally, advancements in veterinary medicine and the development of more effective and safer deworming products have further fueled market growth. The market is characterized by a mix of established pharmaceutical companies and emerging players, all striving to innovate and capture a share of this expanding market. As pet owners become more informed and proactive about their pets' health, the demand for effective internal dewormers is expected to continue rising, making this a dynamic and evolving market.

Companion Animal Internal Dewormer Market

Tablet, Powder in the Global Companion Animal Internal Dewormer Market:

In the Global Companion Animal Internal Dewormer Market, tablets and powders are two of the most common forms of deworming products available. Tablets are often favored for their convenience and ease of administration. They can be easily given to pets, either directly or mixed with food, making them a popular choice among pet owners. Tablets are typically formulated to target specific types of internal parasites, such as roundworms, hookworms, and tapeworms, and are designed to be palatable to ensure pets readily consume them. The effectiveness of tablet-based dewormers is well-documented, and they are often recommended by veterinarians for their precise dosing and reliable results. On the other hand, powder dewormers offer a versatile alternative, particularly for pets that may be difficult to medicate with tablets. Powders can be mixed with food or water, making them an ideal option for pets that are picky eaters or have difficulty swallowing pills. Like tablets, powder dewormers are formulated to combat a range of internal parasites and are available in various strengths and formulations to suit different animal sizes and species. The choice between tablets and powders often depends on the pet's preferences, the owner's convenience, and the specific health needs of the animal. Both forms have their advantages, and the decision is usually guided by veterinary advice to ensure the best possible outcome for the pet's health. As the market continues to evolve, manufacturers are focusing on improving the palatability, efficacy, and safety of both tablets and powders, ensuring they meet the diverse needs of pet owners and their furry companions.

Dogs, Cats, Other in the Global Companion Animal Internal Dewormer Market:

The usage of Global Companion Animal Internal Dewormer Market products varies across different types of pets, with dogs, cats, and other animals each having unique requirements. For dogs, internal dewormers are essential for preventing and treating infestations of common parasites such as roundworms, hookworms, and tapeworms. These parasites can cause a range of health issues, from digestive problems to more severe conditions like anemia and malnutrition. Deworming is typically recommended as part of a regular health maintenance routine, with puppies often requiring more frequent treatments due to their developing immune systems. For cats, internal dewormers are equally important, as they are susceptible to similar parasites. Cats can contract these parasites through various means, including hunting and consuming infected prey or coming into contact with contaminated environments. Regular deworming helps prevent the spread of parasites and protects the cat's overall health. In addition to dogs and cats, other companion animals such as rabbits, ferrets, and small rodents may also require deworming, although the specific products and treatment regimens can vary significantly. These animals can be prone to different types of parasites, and their deworming needs are often determined by their living conditions and exposure risks. In all cases, the use of internal dewormers is guided by veterinary recommendations, ensuring that each pet receives the appropriate treatment for their specific health needs. As awareness of pet health continues to grow, the demand for effective deworming solutions is expected to increase, highlighting the importance of these products in maintaining the health and well-being of companion animals.

Global Companion Animal Internal Dewormer Market Outlook:

The global market for Companion Animal Internal Dewormer was valued at approximately $3,029 million in 2024, and it is anticipated to expand to a revised size of around $4,529 million by 2031. This growth trajectory represents a compound annual growth rate (CAGR) of 6.0% over the forecast period. This upward trend is indicative of the increasing importance placed on pet health and the proactive measures pet owners are taking to ensure their animals are free from internal parasites. The market's growth is fueled by several factors, including the rising number of pet owners worldwide, advancements in veterinary medicine, and the development of more effective and safer deworming products. As pets are increasingly viewed as integral members of the family, there is a growing emphasis on their health and well-being, which in turn drives the demand for high-quality deworming solutions. The market is characterized by a diverse range of products, including tablets, powders, and liquids, each catering to different types of animals and their specific needs. As the market continues to evolve, manufacturers are focusing on innovation and product development to capture a share of this expanding market. The projected growth of the Companion Animal Internal Dewormer Market underscores the importance of these products in maintaining the health and well-being of pets worldwide.


Report Metric Details
Report Name Companion Animal Internal Dewormer Market
Accounted market size in year US$ 3029 million
Forecasted market size in 2031 US$ 4529 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablet
  • Powder
Segment by Application
  • Dogs
  • Cats
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Companion Animal External Dewormer Market Research Report 2025

What is Global Companion Animal External Dewormer Market?

The Global Companion Animal External Dewormer Market is a specialized segment within the broader animal healthcare industry, focusing on products designed to eliminate parasitic worms in pets such as dogs, cats, and other companion animals. These dewormers are crucial for maintaining the health and well-being of pets, as parasitic infections can lead to severe health issues, including malnutrition, anemia, and even death if left untreated. The market encompasses a variety of products, including oral medications, topical treatments, and injectable solutions, each tailored to different types of parasites and levels of infestation. The demand for these products is driven by increasing pet ownership, heightened awareness of pet health, and the growing trend of treating pets as family members. Additionally, advancements in veterinary medicine and the development of more effective and safer deworming products have further fueled market growth. The market is characterized by a mix of established pharmaceutical companies and emerging players, all striving to innovate and capture a share of this expanding market. As pet owners become more informed and proactive about their pets' health, the Global Companion Animal External Dewormer Market is poised for continued growth and evolution.

Companion Animal External Dewormer Market

Injection, Unguent in the Global Companion Animal External Dewormer Market:

In the realm of the Global Companion Animal External Dewormer Market, injections and unguents play a pivotal role in the effective management and eradication of parasitic infections in pets. Injections, often administered by veterinarians, provide a direct and potent method of delivering deworming medication into an animal's system. This method is particularly beneficial for severe infestations or when rapid action is required. Injectable dewormers are designed to target specific parasites and are often used in conjunction with other treatments to ensure comprehensive parasite control. The precision and efficacy of injections make them a preferred choice for many veterinary professionals, especially in clinical settings where immediate results are necessary. On the other hand, unguents, or topical treatments, offer a more user-friendly and less invasive option for pet owners. These products are applied directly to the animal's skin, usually at the base of the neck or along the back, where they are absorbed into the bloodstream. Unguents are particularly popular for their ease of application and the convenience they offer to pet owners who may be uncomfortable with administering oral medications or injections. They are also effective in targeting external parasites such as fleas and ticks, providing a dual benefit of deworming and external parasite control. The formulation of unguents has evolved significantly, with many products now offering long-lasting protection and being water-resistant, ensuring that pets remain protected even after bathing or swimming. The choice between injections and unguents often depends on the specific needs of the pet, the type of parasites being targeted, and the preferences of the pet owner. Both methods have their advantages and are integral to the comprehensive management of parasitic infections in companion animals. As the Global Companion Animal External Dewormer Market continues to grow, innovations in both injectable and topical treatments are expected to enhance their efficacy, safety, and ease of use, further solidifying their place in the arsenal of tools available to pet owners and veterinarians alike.

Dogs, Cats, Other in the Global Companion Animal External Dewormer Market:

The usage of Global Companion Animal External Dewormer Market products varies across different types of pets, with specific considerations for dogs, cats, and other companion animals. For dogs, dewormers are essential in preventing and treating a range of parasitic infections, including those caused by roundworms, hookworms, tapeworms, and whipworms. Dogs are often exposed to these parasites through their environment, such as contaminated soil or feces, making regular deworming a critical component of their healthcare regimen. Deworming products for dogs are available in various forms, including oral tablets, chewables, and topical solutions, allowing pet owners to choose the most suitable option for their pets. Cats, on the other hand, are prone to different types of parasitic infections, with roundworms and tapeworms being the most common. Cats can contract these parasites through hunting or ingesting infected fleas, making deworming an important preventive measure. Dewormers for cats are typically available in oral and topical forms, with formulations specifically designed to cater to their unique physiology and behavior. The ease of administration is a key consideration for cat owners, as cats can be more challenging to medicate compared to dogs. In addition to dogs and cats, other companion animals such as rabbits, ferrets, and guinea pigs also benefit from deworming treatments. These animals can be susceptible to various internal and external parasites, and deworming products tailored to their specific needs are available in the market. The choice of dewormer for these animals often depends on the type of parasite, the severity of the infestation, and the animal's overall health. As pet ownership continues to rise globally, the demand for effective and safe deworming products for all types of companion animals is expected to increase, driving further innovation and growth in the Global Companion Animal External Dewormer Market.

Global Companion Animal External Dewormer Market Outlook:

The outlook for the Global Companion Animal External Dewormer Market is promising, with significant growth anticipated over the coming years. In 2024, the market was valued at approximately US$ 2305 million, reflecting the increasing demand for effective deworming solutions for pets. This demand is driven by a combination of factors, including rising pet ownership, greater awareness of pet health, and advancements in veterinary medicine. As more people around the world embrace pets as integral members of their families, the need for comprehensive healthcare solutions, including dewormers, continues to grow. By 2031, the market is projected to reach a revised size of US$ 3446 million, representing a compound annual growth rate (CAGR) of 6.0% during the forecast period. This growth trajectory underscores the expanding opportunities within the market, as companies strive to develop innovative products that meet the evolving needs of pet owners and veterinarians. The market's expansion is also fueled by the increasing availability of a wide range of deworming products, from oral medications to topical treatments and injectables, catering to different types of pets and levels of infestation. As the Global Companion Animal External Dewormer Market continues to evolve, it is poised to play a crucial role in enhancing the health and well-being of pets worldwide, ensuring that they lead happy and healthy lives alongside their human companions.


Report Metric Details
Report Name Companion Animal External Dewormer Market
Accounted market size in year US$ 2305 million
Forecasted market size in 2031 US$ 3446 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Unguent
Segment by Application
  • Dogs
  • Cats
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Animal Anti-infectives Market Research Report 2025

What is Global Animal Anti-infectives Market?

The Global Animal Anti-infectives Market is a crucial segment within the broader veterinary pharmaceuticals industry, focusing on products designed to prevent and treat infections in animals. These anti-infectives include antibiotics, antivirals, antifungals, and antiparasitics, which are essential for maintaining animal health and ensuring the safety of animal-derived food products. The market is driven by the increasing demand for animal protein, rising pet ownership, and the need to prevent zoonotic diseases, which are diseases that can be transmitted from animals to humans. Additionally, the growing awareness of animal health and welfare, coupled with advancements in veterinary medicine, has led to the development of more effective and targeted anti-infective products. The market is also influenced by regulatory frameworks that aim to control the use of antibiotics in animals to prevent antibiotic resistance, a significant public health concern. As a result, there is a growing emphasis on developing alternative therapies and vaccines to reduce reliance on traditional antibiotics. The Global Animal Anti-infectives Market is characterized by a diverse range of products and a competitive landscape, with numerous companies investing in research and development to innovate and expand their product offerings.

Animal Anti-infectives Market

Injection, Unguent in the Global Animal Anti-infectives Market:

In the Global Animal Anti-infectives Market, injections and unguents play a pivotal role in delivering therapeutic agents to animals. Injections are a common method of administering anti-infectives, especially when rapid action is required or when the animal's condition necessitates a precise dosage. Injectable anti-infectives are often used in livestock and pets to treat bacterial infections, as they ensure that the medication is delivered directly into the bloodstream, providing quick relief and effective treatment. The use of injections is particularly prevalent in large-scale livestock operations, where the health of the herd is paramount, and any delay in treatment could lead to significant economic losses. Injections are also favored for their ability to bypass the digestive system, which can sometimes degrade the efficacy of oral medications. On the other hand, unguents, or topical treatments, are used to treat localized infections or skin conditions in animals. These formulations are applied directly to the affected area, allowing for targeted treatment with minimal systemic absorption. Unguents are particularly useful for treating wounds, skin infections, and parasitic infestations, providing a protective barrier and delivering the active ingredient directly to the site of infection. The choice between injections and unguents depends on various factors, including the type of infection, the animal species, and the severity of the condition. Injections are often preferred for systemic infections, while unguents are ideal for localized issues. Both forms of administration have their advantages and limitations, and veterinarians must carefully consider these factors when prescribing treatment. The development of new injection and unguent formulations is a key focus for companies in the Global Animal Anti-infectives Market, as they seek to improve efficacy, reduce side effects, and enhance the overall treatment experience for animals and their caregivers. Innovations in delivery systems, such as long-acting injectables and advanced topical formulations, are helping to address some of the challenges associated with traditional anti-infective therapies. As the market continues to evolve, the demand for effective and convenient treatment options is expected to drive further advancements in injection and unguent technologies.

Livestock, Pets in the Global Animal Anti-infectives Market:

The usage of Global Animal Anti-infectives Market products in livestock and pets is essential for maintaining animal health and preventing the spread of infectious diseases. In the livestock sector, anti-infectives are used to treat and prevent infections in animals raised for food production, such as cattle, poultry, and swine. These animals are often kept in close quarters, which can facilitate the rapid spread of infections. Anti-infectives help to ensure that livestock remain healthy, which is crucial for food safety and the economic viability of farming operations. The use of anti-infectives in livestock is subject to strict regulations to prevent the development of antibiotic resistance, and there is a growing emphasis on responsible use and alternative therapies. In the pet sector, anti-infectives are used to treat infections in companion animals, such as dogs and cats. Pets are often considered family members, and their health and well-being are a top priority for their owners. Anti-infectives are used to treat a wide range of conditions in pets, from skin infections to respiratory diseases. The pet market is characterized by a high level of innovation, with companies developing new formulations and delivery methods to improve treatment outcomes and enhance the pet owner's experience. The demand for anti-infectives in the pet sector is driven by the increasing number of pet owners and the growing awareness of pet health and wellness. Both livestock and pet sectors face challenges related to the use of anti-infectives, including the risk of antibiotic resistance and the need for effective alternatives. The Global Animal Anti-infectives Market is responding to these challenges by investing in research and development to create new products that are both effective and safe. This includes the development of vaccines, probiotics, and other non-antibiotic therapies that can help reduce the reliance on traditional anti-infectives. As the market continues to grow, the focus on responsible use and innovation will be key to ensuring the health and well-being of animals and the safety of the food supply.

Global Animal Anti-infectives Market Outlook:

The global market for Animal Anti-infectives was valued at $5,506 million in 2024 and is anticipated to expand to a revised size of $8,232 million by 2031, reflecting a compound annual growth rate (CAGR) of 6.0% over the forecast period. This growth trajectory underscores the increasing demand for effective animal health solutions across the globe. The market's expansion is driven by several factors, including the rising need for animal protein, the growing pet population, and heightened awareness of zoonotic diseases. As consumers become more conscious of food safety and animal welfare, the demand for advanced anti-infective products is expected to rise. Additionally, regulatory measures aimed at controlling antibiotic use in animals are prompting the development of alternative therapies, further fueling market growth. Companies operating in this space are investing heavily in research and development to innovate and expand their product portfolios, ensuring they meet the evolving needs of the market. The competitive landscape is characterized by a mix of established players and emerging companies, all striving to capture a share of this lucrative market. As the market continues to evolve, the focus on innovation, efficacy, and safety will be paramount in driving future growth.


Report Metric Details
Report Name Animal Anti-infectives Market
Accounted market size in year US$ 5506 million
Forecasted market size in 2031 US$ 8232 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Unguent
Segment by Application
  • Livestock
  • Pets
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Pets Anti-infectives Market Research Report 2025

What is Global Pets Anti-infectives Market?

The Global Pets Anti-infectives Market is a specialized segment within the broader veterinary pharmaceutical industry, focusing on products designed to prevent and treat infections in pets. This market encompasses a wide range of anti-infective products, including antibiotics, antifungals, antivirals, and antiparasitics, which are essential for maintaining the health and well-being of pets such as dogs, cats, and other companion animals. The demand for these products is driven by the increasing pet ownership worldwide, coupled with a growing awareness of pet health and hygiene. As pets are increasingly considered family members, their health is prioritized, leading to a rise in veterinary visits and the subsequent demand for effective anti-infective treatments. Additionally, advancements in veterinary medicine and the development of new and improved formulations have further fueled market growth. The market is characterized by a diverse range of products catering to various infections and diseases, ensuring that pet owners have access to effective treatments for their furry companions. Overall, the Global Pets Anti-infectives Market plays a crucial role in safeguarding pet health, contributing to the overall growth and development of the veterinary pharmaceutical industry.

Pets Anti-infectives Market

Injection, Unguent in the Global Pets Anti-infectives Market:

In the Global Pets Anti-infectives Market, injections and unguents are two primary forms of administering anti-infective treatments to pets. Injections are often used for their rapid onset of action and high efficacy, making them a preferred choice for treating severe infections or when immediate intervention is necessary. They are typically administered by veterinarians and are designed to deliver a precise dose of medication directly into the bloodstream, ensuring quick and effective treatment. Injections are particularly useful in cases where oral administration is not feasible, such as with pets that are uncooperative or have gastrointestinal issues that may affect drug absorption. On the other hand, unguents, or topical treatments, are applied directly to the skin or affected area. They are commonly used for treating localized infections, such as skin infections, wounds, or fungal infections. Unguents offer the advantage of targeted treatment, minimizing systemic exposure and potential side effects. They are often preferred for their ease of application and the ability to provide continuous medication release over time. The choice between injections and unguents depends on various factors, including the type and severity of the infection, the pet's overall health, and the owner's preference. Both forms of treatment play a vital role in the Global Pets Anti-infectives Market, offering pet owners and veterinarians a range of options to effectively manage and treat infections in pets. The market for these products is driven by the increasing prevalence of pet infections, the growing awareness of pet health, and the continuous advancements in veterinary medicine. As pet owners become more proactive in seeking medical care for their pets, the demand for effective and convenient anti-infective treatments continues to rise. Injections and unguents are integral components of the Global Pets Anti-infectives Market, providing essential solutions for maintaining pet health and well-being.

Dogs, Cats, Other in the Global Pets Anti-infectives Market:

The usage of Global Pets Anti-infectives Market products varies across different types of pets, including dogs, cats, and other companion animals. For dogs, anti-infective treatments are commonly used to address a wide range of infections, such as skin infections, ear infections, respiratory infections, and gastrointestinal infections. Dogs are prone to various bacterial, fungal, and viral infections due to their active lifestyles and frequent exposure to different environments. Anti-infective products, including antibiotics, antifungals, and antivirals, are essential for treating these infections and ensuring the overall health and well-being of dogs. In the case of cats, anti-infective treatments are often used to manage infections such as upper respiratory infections, urinary tract infections, and skin infections. Cats are susceptible to infections due to their grooming habits and close contact with other animals. Anti-infective products play a crucial role in preventing and treating these infections, helping to maintain the health and longevity of cats. For other companion animals, such as rabbits, guinea pigs, and birds, anti-infective treatments are used to address specific infections that are common in these species. The Global Pets Anti-infectives Market provides a range of products tailored to the unique needs of different pets, ensuring that pet owners have access to effective treatments for their furry and feathered companions. The demand for these products is driven by the increasing pet ownership worldwide, the growing awareness of pet health, and the continuous advancements in veterinary medicine. As pet owners become more proactive in seeking medical care for their pets, the usage of anti-infective treatments continues to rise, contributing to the overall growth and development of the Global Pets Anti-infectives Market.

Global Pets Anti-infectives Market Outlook:

In 2024, the global market for Pets Anti-infectives was valued at approximately $1,901 million. This market is anticipated to expand significantly, reaching an estimated size of $2,843 million by the year 2031. This growth trajectory represents a compound annual growth rate (CAGR) of 6.0% over the forecast period. The expansion of this market can be attributed to several factors, including the increasing pet ownership worldwide, the growing awareness of pet health and hygiene, and the continuous advancements in veterinary medicine. As pets are increasingly considered family members, their health is prioritized, leading to a rise in veterinary visits and the subsequent demand for effective anti-infective treatments. The market is characterized by a diverse range of products catering to various infections and diseases, ensuring that pet owners have access to effective treatments for their furry companions. Overall, the Global Pets Anti-infectives Market plays a crucial role in safeguarding pet health, contributing to the overall growth and development of the veterinary pharmaceutical industry.


Report Metric Details
Report Name Pets Anti-infectives Market
Accounted market size in year US$ 1901 million
Forecasted market size in 2031 US$ 2843 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Unguent
Segment by Application
  • Dogs
  • Cats
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-
Subscribe to: Posts (Atom)

ε-Polylysine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

What is ε-Polylysine- Global Market? ε-Polylysine is a naturally occurring antimicrobial peptide that has gained significant attention in t...